Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Breunig

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of the Peripheral Nervous System : JPNS|December 20, 2011
Small fibers in Fabry disease: baseline and follow-up data under enzyme replacement therapyNurcan Üçeyler, Lan He, Dorothee Schönfeld, et al.
European Journal of Heart Failure|December 15, 2010
Cardiac energy metabolism is disturbed in Fabry disease and improves with enzyme replacement therapy using recombinant human galactosidase AWolfram Machann, Frank Breunig, Frank Weidemann, et al.
Kidney International. Supplement|April 16, 2003
Fabry disease: diagnosis and treatmentFrank Breunig, Frank Weidemann, Meinrad Beer, et al.
Circulation. Cardiovascular Genetics|January 8, 2014
Gene mutations versus clinically relevant phenotypes: lyso-Gb3 defines Fabry diseaseMarkus Niemann, Arndt Rolfs, Stefan Störk, et al.
International Journal of Cardiology|March 13, 2010
Free breathing cardiac real-time cine MR without ECG triggeringMeinrad Beer, Heimo Stamm, Wolfram Machann, et al.
Journal of Inherited Metabolic Disease|October 12, 2012
Cross-sectional baseline analysis of electrocardiography in a large cohort of patients with untreated Fabry diseaseMarkus Niemann, Tanja Hartmann, Mehdi Namdar, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 1, 2013
Reproducibility of manual and semi-automated late enhancement quantification in patients with Fabry diseaseWolfram Machann, Oliver Geier, Sabrina Koeppe, et al.
The American Journal of Cardiology|May 9, 2006
Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathyMeinrad Beer, Frank Weidemann, Frank Breunig, et al.
International Journal of Cardiology|April 6, 2011
MR-based analysis of regional cardiac function in relation to cellular integrity in Fabry diseaseSabrina Koeppe, Henning Neubauer, Frank Breunig, et al.
Circulation|January 21, 2009
Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatmentFrank Weidemann, Markus Niemann, Frank Breunig, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of the Peripheral Nervous System : JPNS|December 20, 2011
Small fibers in Fabry disease: baseline and follow-up data under enzyme replacement therapyNurcan Üçeyler, Lan He, Dorothee Schönfeld, et al.
European Journal of Heart Failure|December 15, 2010
Cardiac energy metabolism is disturbed in Fabry disease and improves with enzyme replacement therapy using recombinant human galactosidase AWolfram Machann, Frank Breunig, Frank Weidemann, et al.
Kidney International. Supplement|April 16, 2003
Fabry disease: diagnosis and treatmentFrank Breunig, Frank Weidemann, Meinrad Beer, et al.
Circulation. Cardiovascular Genetics|January 8, 2014
Gene mutations versus clinically relevant phenotypes: lyso-Gb3 defines Fabry diseaseMarkus Niemann, Arndt Rolfs, Stefan Störk, et al.
International Journal of Cardiology|March 13, 2010
Free breathing cardiac real-time cine MR without ECG triggeringMeinrad Beer, Heimo Stamm, Wolfram Machann, et al.
Journal of Inherited Metabolic Disease|October 12, 2012
Cross-sectional baseline analysis of electrocardiography in a large cohort of patients with untreated Fabry diseaseMarkus Niemann, Tanja Hartmann, Mehdi Namdar, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 1, 2013
Reproducibility of manual and semi-automated late enhancement quantification in patients with Fabry diseaseWolfram Machann, Oliver Geier, Sabrina Koeppe, et al.
The American Journal of Cardiology|May 9, 2006
Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathyMeinrad Beer, Frank Weidemann, Frank Breunig, et al.
International Journal of Cardiology|April 6, 2011
MR-based analysis of regional cardiac function in relation to cellular integrity in Fabry diseaseSabrina Koeppe, Henning Neubauer, Frank Breunig, et al.
Circulation|January 21, 2009
Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatmentFrank Weidemann, Markus Niemann, Frank Breunig, et al.
Pageof 4